NCT00039052View on ClinicalTrials.gov

Intravenous Interleukin-4 PE38KDEL Cytotoxin in Treating Patients With Recurrent or Metastatic Kidney Cancer, Non-Small Cell Lung Cancer, or Breast Cancer

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

January 31, 2002

Primary Completion Date

May 31, 2003

Study Completion Date

July 31, 2008

Conditions
Breast CancerKidney CancerLung Cancer
Interventions
BIOLOGICAL

interleukin-4 PE38KDEL cytotoxin

Trial Locations (2)

85724

Arizona Cancer Center, Tucson

90095-5907

Jonsson Comprehensive Cancer Center, UCLA, Los Angeles

Sponsors
All Listed Sponsors
lead

Neurocrine Biosciences

INDUSTRY